Integrity, diligence, dedication to excellence, creativity and an entrepreneurial spirit are the guiding principles that I follow every day to help achieve successful outcomes for my clients.
Julian advises shareholders, management teams and financial sponsors on complex private and public mergers and acquisitions (M&A) transactions in the global healthcare sector. He has extensive experience in sell-side and buy-side transactions within the healthcare services, medical technology, healthcare information technology, pharmaceuticals and dental sectors.
Julian is passionate about working with exceptional people, truly understanding his client’s needs and goals, their businesses and underlying market dynamics within the rapidly changing global healthcare ecosystem.
Prior to joining Lincoln, Julian worked in the healthcare M&A practice at Raymond James. Previously, he worked at Richmond Park Partners, focused in M&A, and in the investment banking department at Bank of America Merrill Lynch and Berenberg.
Julian earned a Bachelor of Science in business administration from the University of Bamberg.
Recent Transactions in Healthcare
Lincoln International served as the exclusive financial advisor and debt arranger to OrthoFi on its acquisition of OrthoBanc
Lincoln International is pleased to have advised AnGes, Inc. on its acquisition of EmendoBio, Inc., a leader in next-generation novel nuclease discovery and gene editing technologies, at a valuation of $250 million
Lincoln International is pleased to announce that Strive Medical has been acquired by NMS Capital
Lincoln International is pleased to announce that KIMS Property Company Limited, a portfolio company of Magnetar Financial (UK) LLP, has extended its senior facilities
Lincoln International advises New Harbor Capital on the sale of Wedgewood Pharmacy to Partners Group
Lincoln International advised The FSB Companies LLC on the sale of Pinnacle Medical Solutions LLC to AdaptHealth Corp.
Lincoln International advised The Vet Connection on its sale to Pets at Home Group PLC (LSE:PETS)